Association between plasma homocysteine and vascular atherosclerotic disease in older persons

Preventive Cardiology

Volumn 3, Issue 2, 2000, Pages 89-91

  Aronow, W S ^a  

^a HEBREW HOSPITAL HOME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; MULTIVITAMIN;

ADULT; AGED; AGING; AMINO ACID BLOOD LEVEL; ARTERY DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; REVIEW; RISK FACTOR; STROKE; VASCULAR DISEASE;

EID: 0033810856     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2000.80361.x     Document Type: Review

References (36)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
2. Plasma homocyst(e)ine levels in men with premature coronary artery disease
3. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
4. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease
5. 6, pyridoxal phosphate, and folate
6. Homocysteine and coronary atherosclerosis
7. Association between plasma homocysteine and coronary artery disease in older persons
8. Plasma homocysteine levels and mortality in patients with coronary artery disease
9. Homocysteine and ischemic heart disease. Results of prospective study with implications regarding prevention
10. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem
11. Homocysteine and risk of cardiovascular disease among postmenopausal women
12. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination Survey
13. Increased plasma homocysteine is an independent predictor of new coronary events in older persons
14. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins. The Atherosclerosis Risk in Communities (ARIC) Study
15. Homocyst(e)ine, diet, and cardiovascular diseases. A statement for health-care professionals from the Nutrition Committee, American Heart Association
16. Homocysteine and atherosclerosis update
17. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
18. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project
19. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans
20. High homocysteine levels are independently related to isolated systolic hypertension in older adults
21. 6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial
22. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: The Framingham study
23. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
24. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
25. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons
26. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study
27. A prospective study of plasma homocysteine and risk of ischemic stroke
28. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis
29. Association between plasma homocysteine and extracranial carotid arterial disease in older persons
30. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
31. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease: Effects of pyridoxine and folic acid treatment
32. Hyperhomocysteinemia: An independent risk factor for vascular disease
33. Hyperhomocyst(e)inemia: An independent risk factor for intermittent claudication
34. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50: Effect of smoking and extent of disease
35. Association between plasma homocysteine and peripheral arterial disease in older persons
36. Correlation between plasma homocyst(e)ine and aortic atherosclerosis